IOBT (STOCKS)
IO Biotech, Inc. Common Stock
$0.382200
+0.026700 (+7.51%)
Prev close: $0.355500
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Mai-Britt Zocca
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $25.59M
- Employees
- 78
- P/E (TTM)
- -0.27
- P/B (TTM)
- 27.20
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
1
Strong Buy
0
Buy
5
Hold
2
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.13 | $-0.33 | +0.2005 | +60.67% |
|
Jun 2025 (Q2)
|
$-0.35 | $-0.36 | +0.0131 | +3.61% |
|
Mar 2025 (Q1)
|
$-0.34 | $-0.39 | +0.0476 | +12.28% |
|
Dec 2024 (Q4)
|
$-0.48 | $-0.40 | -0.0822 | -20.66% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $2.75M |
| Operating Expenses | $92.05M |
| Research and Development | $67.92M |
| Other Operating Expenses | $24.14M |
| Operating Income/Loss | -$92.05M |
| Income/Loss From Continuing Operations After Tax | -$88.36M |
| Income/Loss From Continuing Operations Before Tax | -$89.30M |
| Income Tax Expense/Benefit | -$955.00K |
| Net Income/Loss | -$88.35M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$88.36M |
| Net Income/Loss Available To Common Stockholders, Basic | -$88.35M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.34 |
| Diluted Earnings Per Share | -$1.34 |
| Basic Average Shares | 66,238,484 |
| Diluted Average Shares | 66,238,484 |
| Assets | $39.96M |
| Current Assets | $36.83M |
| Noncurrent Assets | $3.13M |
| Fixed Assets | $544.00K |
| Other Non-current Assets | $2.58M |
| Liabilities | $39.05M |
| Current Liabilities | $18.31M |
| Accounts Payable | $5.59M |
| Wages | $2.99M |
| Other Current Liabilities | $9.74M |
| Noncurrent Liabilities | $20.73M |
| Equity | $911.00K |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $911.00K |
| Liabilities And Equity | $39.96M |
| Net Cash Flow From Operating Activities | -$81.00M |
| Net Cash Flow From Operating Activities, Continuing | -$81.00M |
| Net Cash Flow From Investing Activities | -$69.00K |
| Net Cash Flow From Investing Activities, Continuing | -$69.00K |
| Net Cash Flow From Financing Activities | $52.39M |
| Net Cash Flow From Financing Activities, Continuing | $52.39M |
| Net Cash Flow | -$28.67M |
| Net Cash Flow, Continuing | -$28.67M |
| Comprehensive Income/Loss | -$87.34M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$84.51M |
| Other Comprehensive Income/Loss | $1.02M |